CLGNNasdaq
CollPlant Biotechnologies Ltd
Healthcare·Healthcare·Rehovot, Israel
Key Financials
Market Cap
$4.7M
Cash
$5.6M
Quarterly Burn
—
Runway
—
Revenue
—
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
17
Total value held
$767K
| Holder | Shares | Value |
|---|---|---|
| villere st denis j & co llc | 607,300 | $326K |
| pinnacle associates ltd | 550,229 | $295K |
| brown advisory inc | 118,731 | $64K |
| armistice capital, llc | 64,000 | $34K |
| citadel advisors llc | 32,165 | $17K |
| renaissance technologies llc | 16,800 | $9K |
| xtx topco ltd | 14,795 | $8K |
| waters parkerson & co., llc | 13,250 | $7K |
| two sigma securities, llc | 11,357 | $6K |
| group one trading llc | 1,400 | $749 |
Showing top 10 of 17 institutional holders of CollPlant Biotechnologies Ltd. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
·CEO: Mr. Yehiel Tal
Frequently asked questions
What is CollPlant Biotechnologies Ltd's market capitalization?
CollPlant Biotechnologies Ltd's market capitalization is approximately $4.7M.
Who is the CEO of CollPlant Biotechnologies Ltd?
Mr. Yehiel Tal is the chief executive officer of CollPlant Biotechnologies Ltd (CLGN).
Get the full picture on CollPlant Biotechnologies Ltd
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.